A landmark decade-long clinical trial has established that stereotactic radiation therapy delivers survival outcomes on par with surgical resection in early-stage non-small cell lung cancer patients. This pivotal study advocates for less invasive treatments, potentially reshaping standards of care and improving patient quality of life. Complementary findings from head and neck cancer trials further reinforce proton and intensity-modulated radiotherapy equivalence, expanding radiation therapy applicability.